COMMUNIQUÉS West-GlobeNewswire

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2024
BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on April 30, 2024, the [...]
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
01/05/2024
MENLO PARK, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, [...]
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
01/05/2024
DEER PARK, Ill., May 01, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced today [...]
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
01/05/2024
LAUSANNE, Switzerland, May 01, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company has made grants of options to purchase an aggregate of 147,600 of the Company’s common shares to [...]
RxSight, Inc. to Present at the Bank of America Healthcare Conference
01/05/2024
ALISO VIEJO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]
Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference
01/05/2024
FRANKLIN, Tenn., May 01, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to [...]
Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
01/05/2024
SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
01/05/2024
SCOTTSDALE, Ariz., May 01, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and [...]
Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab
01/05/2024
An NCI-supported Phase 2 investigator-initiated trial at the Providence Cancer Institute in Portland, Oregon, has enrolled its first patient in a study exploring the combination of pembrolizumab (Keytruda®) and Galecto’ [...]
LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024
01/05/2024
SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop [...]
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
01/05/2024
Enhances strategic flexibility and control of key gene editing technologies and programs EMERYVILLE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company [...]
MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
01/05/2024
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2024 first quarter financial results and its management will host a conference call to [...]
Koelis Announces New Product Release at AUA 2024 to Offer Innovative AI-Enhanced MRI Fusion Biopsy Workflow
01/05/2024
GRENOBLE, France and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com ), a leader and innovator in prostate care, announced today the release of new features at [...]
Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond
01/05/2024
Ad hoc announcement pursuant to Art. 53 LR The proposed consent fee will be increased to 8’000’000 Idorsia shares. All other matters as proposed on April 23, 2024, remain unchanged. The bondholder meeting will take [...]
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
01/05/2024
Nearly 9 in 10 Americans surveyed agree opioid overdoses are a concern for teenagers and college students; parents in the survey want life-saving treatment to be easily accessible in case of an emergency GAITHERSBURG, [...]
WAKE RADIOLOGY TEAM RALLIES TO SUPPORT TRIANGLE RACE FOR THE CURE
01/05/2024
RESEARCH TRIANGLE PARK, N.C., May 01, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC REX Healthcare, the oldest and largest outpatient imaging provider in the Triangle, announced today it is once again sponsoring the Susan [...]
Seasoned Physician Executive Joins Nymbl Science
01/05/2024
Digital health leader welcomes Dr. Bob Mirsky as Chief Medical Officer DENVER, May 01, 2024 (GLOBE NEWSWIRE) -- Nymbl Science , a digital health provider and leader in scalable fall prevention and bladder training for [...]
Simms/Mann Family Foundation Recognizes Extraordinary Nurses in Second Year of “Off the Chart: Rewarding Nursing Greatness” Campaign
01/05/2024
Forty nurses from Los Angeles-area health systems each receive a $10,000 gift of gratitude for their leadership, ingenuity and expertise in caring for their fellow humans and future generations LOS ANGELES, May 01, 2024 [...]
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
01/05/2024
End-of-day, Thursday, May 2, 2024, Will be the Last and Final Day to Trade SAVAW Warrants on NASDAQ. Monday, May 6, 2024, Will be the Last and Final Day to Cash-Exercise SAVAW Warrants. ‘Notice of Guaranteed Delivery’ [...]

Pages